The severe shortage of donor organs has provided a strong impetus to push t
he investigation into the use of animal organs for humans. Xenotransplantat
ion will not only benefit patients, but also represents a unique and potent
ially profitable business opportunity. However, there are many barriers to
successful clinical xenotransplantation, including immunological barriers,
physiological incompatibility, zoonosis and ethical concerns. This overview
will focus on currently available animal models used in attempts to break
through the immunological barriers to xenotransplantation. There are many a
dvantages to using small animal, namely rodent, models in xenotransplantati
on research. For example, the use of the mouse model allows the use of knoc
kout mice and careful dissection of rejection mechanisms at the molecular l
evel. The following models can be used to study hyperacute rejection (HAR):
guinea-pig-to-rat, mouse-to-rabbit, guinea-pig-to-mouse, rat-to-presensiti
sed mouse and rat-to-alpha-Gal knockout mouse. The hamster-to-rat, mouse-to
-rat and rat-to-mouse models are commonly used to study acute vascular reje
ction. Large animal models are complex and expensive, but they are more rel
evant to clinical xenotransplantation. Based on experiments using transgeni
c pig-to-primate models, HAR can be overcome. However, acute vascular rejec
tion remains a major barrier at the present time. A pig cartilage-to-monkey
model has been developed to study chronic rejection. Other novel models su
ch as pig venous segment-to-monkey model and rat-to-primate model may repre
sent viable options to study immunological barriers following xenotransplan
tation. Like many other medical breakthroughs, animal research will continu
e to make enormous contributions towards the eventual success of xenotransp
lantation.